Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026)
Envoy Medical's (COCH) quarterly Gains from Investment Securities came in at $12000.0 in Q1 2026, up 35.36% year-on-year from $8865.0 in Q1 2025, and up 114.12% quarter-over-quarter from -$85000.0 in Q4 2025.
Envoy Medical (COCH) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Envoy Medical has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $12000.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $12000.0, up 35.36% year-over-year; the trailing twelve-month figure through Mar 2026 was -$884000.0 (down 10071.8% YoY), and the FY2025 annual result was $348280.0, down 84.27% from the prior year.
- Gains from Investment Securities came in at $12000.0 for Q1 2026 at Envoy Medical, up from -$85000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $693000.0 in Q3 2025 to a low of -$14.4 million in Q1 2022.
- The 5-year median for Gains from Investment Securities is -$37000.0 (2025), against an average of -$1.2 million.
- Across the five-year window, Gains from Investment Securities tumbled 2911.97% in 2022 and jumped 396.76% in 2025, its largest moves.
- Envoy Medical's Gains from Investment Securities stood at -$30000.0 in 2022, then tumbled by 576.67% to -$203000.0 in 2023, then plunged by 281.28% to -$774000.0 in 2024, then soared by 89.02% to -$85000.0 in 2025, then jumped by 114.12% to $12000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $12000.0 (Q1 2026), -$85000.0 (Q4 2025), and $693000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Envoy Medical | 44.81 Mn | 19.56 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,000.00 |
| Mar 31, 2026 | 12,000.00 |
| Dec 31, 2025 | -85,000.00 |
| Dec 31, 2025 | -85,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Sep 30, 2025 | 693,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -37,000.00 |
| Mar 31, 2025 | 8,865.00 |
| Mar 31, 2025 | 8,865.00 |
| Dec 31, 2024 | -774,000.00 |
| Dec 31, 2024 | -774,000.00 |
| Sep 30, 2024 | 139,505.00 |
| Sep 30, 2024 | 139,505.00 |
| Jun 30, 2024 | -244,000.00 |
| Jun 30, 2024 | -244,000.00 |
| Mar 31, 2024 | 31,955.00 |
| Mar 31, 2024 | 31,955.00 |
| Dec 31, 2023 | -203,000.00 |
| Dec 31, 2023 | -203,000.00 |